Astex Pharmaceuticals Announces Oral Presentation of SGI-110 Data

barbara.lempert Astex Pharmaceuticals Announces Oral Presentation of SGI-110 Data at the Upcoming European Cancer Congress (ECCO-ESMO-ESTRO)      Correlation of Biomarkers and ...

Horizon Discovery and Hisun Pharmaceuticals Partner on Gene-Engineered Bioproduction Cell Line

barbara.lempert Precisely engineered CHO cell line will enable faster, more efficient development in production of therapeutic antibodies Cambridge, UK, 18 June 2013: Horizon Discovery ...

Astex Pharmaceuticals Announces Presentation of Updated Results of SGI-110-01 Study

barbara.lempert Astex Pharmaceuticals Announces Presentation of Updated Results of SGI-110-01 Study in Patients With Intermediate or High Risk Relapsed or Refractory Myelodysplastic ...

Acetylon Pharmaceuticals Presents Encouraging Safety and Clinical Response Data from Ongoing Clinical Trials of ACY-1215

barbara.lempert Acetylon Pharmaceuticals Presents Encouraging Safety and Clinical Response Data from Ongoing Clinical Trials of ACY-1215 for the Treatment of Multiple Myeloma — ...

J&J to Acquire Aragon Pharmaceuticals for Close to $1B

barbara.lempert Johnson & Johnson Announces Definitive Agreement To Acquire Aragon Pharmaceuticals, Inc. Late-Stage Prostate Cancer Treatment Strengthens Oncology Pipeline NEW ...

DSMB Recommends Continuation of Sunesis Pharmaceuticals’ VALOR Trial

barbara.lempert Data and Safety Monitoring Board Recommends Continuation of Sunesis Pharmaceuticals’ VALOR Trial With no Change to Study Conduct SOUTH SAN FRANCISCO, Calif., ...

ACETO Names Satish Srinivasan as Rising Pharmaceuticals’ President and COO

barbara.lempert PORT WASHINGTON, N.Y., June 13, 2013 (GLOBE NEWSWIRE) — ACETO Corporation (Nasdaq:ACET), a global leader in the marketing, sale and distribution of products for ...

Questcor Pharmaceuticals Acquires Rights to Synacthen

barbara.lempert – Expands Questcor’s Presence in Inflammatory and Autoimmune Disorders – – Provides Foundation for Next Generation Melanocortin Receptor Agonist ...

Takeda’s Millennium Pharmaceuticals R&D rejig unfolds

Ryan McBride Last month, Millennium CEO Deborah Dunsire stepped down and company veteran Anna Protopapas stepped in as president of the company, which will no longer operate as autonomously ...

Idenix Pharmaceuticals Appoints Charles Rowland to Its Board of Directors

barbara.lempert CAMBRIDGE, Mass., June 10, 2013 (GLOBE NEWSWIRE) — Idenix Pharmaceuticals, Inc. (Nasdaq:IDIX), a biopharmaceutical company engaged in the discovery and development ...

Sagent Pharmaceuticals Initiates a Nationwide Voluntary Recall

barbara.lempert Sagent Pharmaceuticals Initiates a Nationwide Voluntary Recall of Three Lots of Vecuronium Bromide for Injection, 10mg Manufactured by Mustafa Nevzat (MN Pharmaceuticals) ...

AMAG Pharmaceuticals Announces Submission of a Type II Variation for Rienso Label Expansion

barbara.lempert AMAG Pharmaceuticals Announces Submission of a Type II Variation for Rienso Label Expansion in Europe to Include All Adult Iron Deficiency Anemia Patients Who Cannot ...
Page 5 of 6« First...23456
© 2018 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS